Role of Metabolomics in Gallbladder Carcinoma
Abstract
Gallbladder cancer (GBC), the most common malignancy of the biliary tract, ranks as the sixth most prevalent gastrointestinal cancer worldwide. Among emerging approaches in GBC management, metabolomics has shown significant promise. By enabling comprehensive profiling of metabolites—small molecules generated in biological systems—metabolomics offers valuable insights for early diagnosis, biomarker discovery, therapeutic targeting, and personalized treatment strategies. This chapter highlights the application of metabolomics in GBC, focusing on its role in unraveling disease pathogenesis and advancing diagnostic and therapeutic interventions.
Fields of Study & Subjects
Cholangiocarcinoma and Gallbladder Cancer Studies
Gallbladder and Bile Duct Disorders
Metabolomics and Mass Spectrometry Studies
Publication details
- Journal / source
- CRC Press eBooks
- Pages
- 85–95
- Publication date
- 11 March 2026
- Language
- EN
- Document type
- Book chapter